DeepMed Research

COOK GROUP INCORPORATED

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Zilver PTX Delivery System

Not Applicable

Completed

Conditions: Peripheral Vascular Disease

Interventions: Device: Zilver® PTX® Drug-Eluting Peripheral Stent

First Posted Date: 2014-10-22

Last Posted Date: 2016-02-26

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 40

Registration Number: NCT02271529

Locations: 🇦🇺
Frankston Hospital, Frankston, Australia
🇳🇿
Waikato Hospital, Hamilton, New Zealand
🇦🇺
Princess Alexandra Hospital, Woolloongabba, Australia

and more 3 locations

Zilver PTX Post-Market Study in Japan

Not Applicable

Completed

Conditions: Peripheral Arterial Disease (PAD)

Interventions: Device: Zilver PTX Drug-Eluting Stent

First Posted Date: 2014-10-02

Last Posted Date: 2019-07-12

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 909

Registration Number: NCT02254837

Zilver Flex Post-Market Study in Japan

Not Applicable

Completed

Conditions: Peripheral Arterial Disease (PAD)

Interventions: Device: Zilver Flex Bare Metal Stent

First Posted Date: 2014-10-01

Last Posted Date: 2018-03-30

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 239

Registration Number: NCT02254356

Locations: 🇯🇵
Fukuoka Sanno Hospital, Fukuoka, Japan

Zilver® PTX® in China

Not Applicable

Completed

Conditions: Peripheral Artery Disease

Interventions: Device: Zilver® PTX® Drug-Eluting Peripheral Stent

First Posted Date: 2014-06-24

Last Posted Date: 2017-03-22

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 178

Registration Number: NCT02171962

Locations: 🇨🇳
China-Japan Friendship Hospital, Beijing, China
🇨🇳
Peking University People's Hospital, Beijing, China
🇨🇳
Peking Union Medical College Hospital, Beijing, China

and more 6 locations

Pilot Safety Study of Injectable SIS for Critical Limb Ischemia

Not Applicable

Completed

Conditions: Peripheral Vascular Disease
Critical Limb Ischemia
Peripheral Arterial Disease

Interventions: Device: Injectable SIS

First Posted Date: 2014-05-23

Last Posted Date: 2017-12-21

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 13

Registration Number: NCT02145845

Locations: 🇨🇿
University Hospital Ostrava, Ostrava, Czechia

Evolution® Biliary Stent System-Fully Covered

Not Applicable

Completed

Conditions: Carcinomas/Neoplasms

Interventions: Device: Evolution® Biliary Stent-Fully Covered

First Posted Date: 2014-04-04

Last Posted Date: 2017-07-05

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 90

Registration Number: NCT02104076

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇫🇷
Hôpital Edouard Herriot, Lyon Cedex 03, France
🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

and more 9 locations

Post-market Observational Study Zenith® t-Branch™

Completed

Conditions: Aortic Aneurysm
Thoracoabdominal

Interventions: Device: Zenith® t-Branch™ Thoracoabdominal Endovascular Graft

First Posted Date: 2014-04-04

Last Posted Date: 2020-01-27

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 80

Registration Number: NCT02104089

Locations: 🇩🇪
Universitäts Krankenhaus Eppendorf, Hamburg, Germany
🇩🇪
St. Franziscus Hospital-GmbH, Münster, Germany
🇸🇪
Skaane University Hospital, Malmö, Sweden

Study of Hemospray for Lower Gastrointestinal Hemorrhage

Completed

Conditions: Colonic Polyp
Colonic Diverticula
Angiodysplasia

Interventions: Device: Hemospray

First Posted Date: 2014-03-28

Last Posted Date: 2017-01-20

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 50

Registration Number: NCT02099435

Locations: 🇨🇦
Montreal General Hospital - McGill University, Montreal, Quebec, Canada
🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada

and more 1 locations

Zenith® Dissection Endovascular System

Not Applicable

Completed

Conditions: Aortic Dissection

Interventions: Device: Zenith® Dissection Endovascular Graft

First Posted Date: 2014-03-21

Last Posted Date: 2017-02-06

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 26

Registration Number: NCT02094300

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Massachusetss General Hospital, Boston,, Massachusetts, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

and more 2 locations

Cook Micronized Small Intestinal Submucosa (SIS) for Critical Limb Ischemia

Not Applicable

Completed

Conditions: Peripheral Arterial Disease
Peripheral Vascular Diseases
Ischemia

Interventions: Device: Micronized Small Intestinal Submucosa (SIS)

First Posted Date: 2014-01-24

Last Posted Date: 2017-01-06

Lead Sponsor: Cook Group Incorporated

Target Recruit Count: 10

Registration Number: NCT02044666

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy